EASL Clinical Practice Guidelines on the management of benign liver tumours
Top Cited Papers
- 12 April 2016
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 65 (2), 386-398
- https://doi.org/10.1016/j.jhep.2016.04.001
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Hepatic hemangiomas: Difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodiumEuropean Journal of Radiology, 2012
- Evaluation of Liver LesionsClinics in Liver Disease, 2012
- Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular studyHistopathology, 2012
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomasThe Journal of Experimental Medicine, 2011
- Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classificationHepatology, 2011
- Hepatocellular adenoma management and phenotypic classification: The Bordeaux experienceHepatology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumoursNature, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literatureBritish Journal of Sports Medicine, 2005